Predictive role of serum HBsAg and HBcrAg kinetics in patients with HBeAg-negative chronic hepatitis B receiving pegylated interferon–based therapy

Clinical Microbiology and Infection - Tập 24 - Trang 306.e7-306.e13 - 2018
N. Chuaypen1, N. Posuwan2, S. Chittmittraprap1, N. Hirankarn3, S. Treeprasertsuk4, Y. Tanaka5, N. Shinkai5, Y. Poovorawan2, P. Tangkijvanich1
1Research Unit of Hepatitis and Liver Cancers, Thailand
2Center of Excellence in Clinical Virology, Thailand
3Immunology Unit, Department of Microbiology, Thailand
4Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
5Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

Thông tin
Thông tin xuất bản

Clinical Microbiology and Infection

Tập 24

306.e7-306.e13

Thông tin tác giả